KPV (5 mg Vial)
Dosing & reconstitution protocol
Quick Reference
Overview
KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of α-melanocyte-stimulating hormone (α-MSH) with potent anti-inflammatory and immunomodulatory properties. Research applications include gut inflammation models, skin barrier studies, and cytokine regulation. At 2 mg/mL, 1 unit on a U-100 syringe = 0.02 mg. The 5 mg vial reconstituted to 2.5 mL provides approximately 100 doses of 0.5 mg.
Dosing & Reconstitution Guide
| Phase | Daily Dose | Units | Volume |
|---|---|---|---|
| Week 1–2 | 0.5 mg per dose | 25 units | 0.25 mL |
| Week 3–4 | 1.0 mg per dose | 50 units | 0.50 mL |
| Week 5–8 (optional) | 2.0 mg per dose | 100 units | 1.00 mL |
Reconstitution Instructions
Draw 2.5 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 28 days.
This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- ✓KPV Vials (5 mg): 2 vials
- ✓Insulin Syringes (U-100): 56 syringes
- ✓Bacteriostatic Water (10 mL): 1 bottle
- ✓Alcohol Swabs: 112 swabs
Dosing Protocol
Schedule
Administer once or twice daily via subcutaneous injection. For GI-focused research, oral or rectal administration routes are also explored in the literature — consult source protocols.
Cycle Length
4–8 weeks, with a 4-week off period before repeating.
Timing
Morning and evening dosing (split daily dose) maintains more consistent peptide exposure throughout the research period.
Storage & Handling
- ✓Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
- ✓Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
- ✓Allow vials to reach room temperature before opening to reduce condensation uptake.
- ✓Do not freeze reconstituted solution.
- ✓Discard if solution becomes cloudy or contains visible particles.
Important Notes
- ✓All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
- ✓Use new sterile insulin syringes for each injection; dispose in a sharps container.
- ✓Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- ✓Inject slowly; wait a few seconds before withdrawing the needle.
- ✓Document daily dose and site rotation to maintain consistency.
- ✓KPV is stable at physiological pH. Avoid prolonged exposure to air after reconstitution.
- ✓For studies involving the gastrointestinal tract, note that peptide bioavailability via injection vs. oral routes differs substantially.